Involvement of spinal kappa opiod receptors in the antagonistic effect of dynorphins on morphine antinociception
- 31 December 1991
- journal article
- Published by Elsevier in Life Sciences
- Vol. 48 (15) , 1447-1453
- https://doi.org/10.1016/0024-3205(91)90181-a
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Stereochemical studies on medicinal agents. 31. Only one pharmacophore is required for the .kappa. opioid antagonist selectivity of norbinaltorphimineJournal of Medicinal Chemistry, 1988
- Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonistEuropean Journal of Pharmacology, 1988
- Intrathecally administered dynorphin-(1–17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant ratsEuropean Journal of Pharmacology, 1987
- Comparative spinal analgesic action of dynorphin1-8, dynorphin1-13, and a kappa-receptor agonist U50,488Canadian Journal of Physiology and Pharmacology, 1986
- Dynorphin-A-(1–13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cordPeptides, 1985
- Dynorphin1–13: interaction with other opiate ligand bindings in vitroBrain Research, 1984
- Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin CircuitryAnnual Review of Neuroscience, 1984
- Dynorphin: Potent analgesic effect in spinal cord of the ratLife Sciences, 1982
- Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptorNature, 1982
- Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regionsNature, 1982